Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.
Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial.
Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
3D genome organization shapes DNA damage susceptibility to platinum-based drugs.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
3D genome organization shapes DNA damage susceptibility to platinum-based drugs.
3D genome organization shapes DNA damage susceptibility to platinum-based drugs. Nucleic Acids Res. 2025 May 22; 53(10).
View in:
PubMed
subject areas
Antineoplastic Agents
Cell Line, Tumor
Cell Nucleus
Chromatin
Cisplatin
DNA Damage
Drug Resistance, Neoplasm
Genome, Human
Humans
Platinum
authors with profiles
Xiang Zhou